# NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/par-21-306-nci-research-specialist-clinician-scientist-award-r50/  
Official notice: https://www.grants.gov/search-results-detail/335377

> National Institutes of Health offered grants to colleges and universities, state and local governments and tribes. Applications closed on October 31, 2023.

| Field | Value |
|---|---|
| Opportunity number | PAR-21-306 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | October 31, 2023 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

## What the grant funds

This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) specifically for clinician scientists supporting NCI-funded clinical trials research. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional clinician scientists who want to continue to participate in the NCI clinical trials networks through leadership in the 1) development of national clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees and other activities, but not serve as principal investigators of research project grants. These clinician scientists are vital to sustaining the NCI-funded clinical trials enterprise. The Research Specialist Award (R50) is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others or other sources of support for career continuity.

## Questions people ask

### Is PAR-21-306 still open?

No. It closed on October 31, 2023. A newer notice is open: PAR-28-063, due dates in the notice, expires February 20, 2029.

### Who can apply for NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from colleges and universities, state and local governments and tribes. The notice adds further conditions, so read its eligibility section.

### What is the deadline for NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)?

Closed October 31, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under PAR-21-306?

NIH RePORTER lists 38 projects funded under PAR-21-306 in fiscal 2023 to 2026, at 32 institutions. The most were at Johns Hopkins University, University of Kansas Medical Center, University of TX MD Anderson Can Ctr.

### Who has won Cancer Cause and Prevention Research grants before?

The largest recipients over five fiscal years were The Univeristy of Texas M.D. Anderson Cancer Center, Sloan-Kettering Institute for Cancer Research, The Trustees of Columbia University in the City of New York. The program made 2,517 awards worth $3.6 billion in that time.